Affiliation:
1. Unit of Endocrinology and Metabolism, Faculty of Medicine and
2. Laboratory of Physiological Chemistry, de Duve Institute of Cellular Pathology, Université Catholique de Louvain, Brussels, Belgium
Abstract
Due to their high glucose permeability, insulin-secreting pancreatic β-cells likely undergo strong intracellular protein glycation at high glucose concentrations. They may, however, be partly protected from the glucotoxic alterations of their survival and function by fructosamine-3-kinase (FN3K), a ubiquitous enzyme that initiates deglycation of intracellular proteins. To test that hypothesis, we cultured pancreatic islets from Fn3k-knockout ( Fn3k−/−) mice and their wild-type (WT) littermates for 1–3 wk in the presence of 10 or 30 mmol/l glucose (G10 or G30, respectively) and measured protein glycation, apoptosis, preproinsulin gene expression, and Ca2+and insulin secretory responses to acute glucose stimulation. The more potent glycating agent d-ribose (25 mmol/l) was used as positive control for protein glycation. In WT islets, a 1-wk culture in G30 significantly increased the amount of soluble intracellular protein-bound fructose-ε-lysines and the glucose sensitivity of β-cells for changes in Ca2+and insulin secretion, whereas it decreased the islet insulin content. After 3 wk, culture in G30 also strongly decreased β-cell glucose responsiveness and preproinsulin mRNA levels, whereas it increased islet cell apoptosis. Although protein-bound fructose-ε-lysines were more abundant in Fn3k−/−vs. WT islets, islet cell survival and function and their glucotoxic alterations were almost identical in both types of islets, except for a lower level of apoptosis in Fn3k−/−islets cultured for 3 wk in G30. In comparison, d-ribose (1 wk) similarly decreased preproinsulin expression and β-cell glucose responsiveness in both types of islets, whereas it increased apoptosis to a larger extent in Fn3k−/−vs. WT islets. We conclude that, despite its ability to reduce the glycation of intracellular islet proteins, FN3K is neither required for the maintenance of β-cell survival and function under control conditions nor involved in protection against β-cell glucotoxicity. The latter, therefore, occurs independently from the associated increase in the level of intracellular fructose-ε-lysines.
Publisher
American Physiological Society
Subject
Physiology (medical),Physiology,Endocrinology, Diabetes and Metabolism
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献